Clinically Advanced Care

Led by 18 board certified or eligible physicians, TUCC strives to provide patients with exemplary urologic care at one location.

read more »

Patient Support

Learn more about our four monthly patient support groups.

read more »

Vasectomy Clinic

In addition to our regular weekly scheduled vasectomies, TUCC is now scheduling vasectomy appointments on the second and fourth Saturday of each month from 8:00 a.m. - 12:00 p.m.

read more »

Headlines in Urology Treatment

Clinical advancements in the field of urology are featured in the news media every day. This section provides patients and physicians with the most up to date information on recent urologic advancements around the world.

* Please Note - TUCC does not necessarily advocate any of the treatment methods listed in the articles below. This news feed is provided as a resource for those interested in the latest urological research occurring around the world.


July 25, 2007

Repeat, High-Dose Chemo Can Cure Testicular Cancer

Intensifying the dose of anticancer drugs can cure a large majority of men with testicular cancer after first-line chemotherapy fails, Indiana University physicians report.

The new findings are published in the July 26 issue of the New England Journal of Medicine.

| Go to story
July 24, 2007

Study tracks 'learning curve' in prostate surgery

The more times a surgeon has performed prostate surgery, the better the odds are for the patient, researchers said Tuesday in a study that validates common-sense advice to get an experienced surgeon.

They tracked success rates of a procedure to remove the prostate gland in men with prostate cancer and documented the "learning curve" doctors face as they perform operations over and over.

| Go to story
July 24, 2007

Broccoli May Help Cut Prostate Cancer

Men who often eat broccoli and cauliflower may be less likely to develop aggressive prostate cancer than men who skimp on those vegetables.

That news appears in the Journal of the National Cancer
Institute.

The finding comes from a study of more than 29,000 U.S. men aged 55 to 74 who were followed for an average of four years.

| Go to story
July 23, 2007

Lycopene fails FDA's scrutiny

This just in: Organic tomatoes have more lycopene than conventionally farmed tomatoes. This also just in: Lycopene may not be as healthful as we thought. So goes the bold field of tomato research.

As the most frequently consumed produce in America after potatoes, tomatoes provide vitamins, minerals and fiber -- and, of course, they're nonfat. Plus, with high levels of the antioxidant lycopene, they've been considered a potentially powerful cancer fighter.

But even as new research identifies which growing methods produce the most lycopene-rich tomatoes, the Food and Drug Administration has said the fruit's health-boosting powers can't be proved.

| Go to story
July 16, 2007

New test may tell who needs prostate surgery

Scientists have found a new way to identify a particularly deadly form of prostate cancer a breakthrough that could save tens of thousands of men from undergoing unnecessary surgery each year.

In contrast to many cancers, only certain prostate tumours require treatment. Many are slow-growing and pose little threat to health. But separating the "tigers" from the "pussycats" — as oncologists dub them — is tricky.

| Go to story
July 16, 2007

New Paint Helps Surgeons See Tumors

U.S. scientists have created a tumor paint to enable surgeons to see cancer cells 500 times better than with current technologies.

The paint was created by researchers at the Seattle Children's Hospital Research Institute and the Fred Hutchinson Cancer Research Center. The scientists said the paint will help surgeons see where a tumor begins and ends more precisely by illuminating the cancerous cells.

| Go to story
July 10, 2007

No evidence lycopene thwarts cancer: FDA

Claims for the cancer-preventing potential of tomatoes and lycopene should be sharply limited, the US Food and Drug Administration has concluded.

| Go to story
July 10, 2007

New Drug Fights Tough-to-Treat Prostate Cancer

The experimental drug abiraterone, which prevents testosterone production anywhere in the body, may reduce blood levels of the prostate cancer marker prostate-specific antigen (PSA) by half, new research shows.

The study also found that the drug can shrink tumors in men whose prostate cancer has continued to grow despite treatment.

| Go to story
July 2, 2007

Analysis: Electricity Used to Kill Cancer

U.S. researchers said Monday that focused electric pulses can puncture holes into cancer cells, killing those cells without using extremes of heat or cold that can damage other tissues.

In laboratory experiments, a one-minute test utilizing irreversible electroporation destroyed 92 percent of tumors in mice, said Rafael Davalos, assistant professor of biomedical engineering at Virginia Tech in Blacksburg.

| Go to story
June 29, 2007

Few Men Aware of Prostate Cancer Trials

A survey of 2,000 U.S. cancer survivors found only 12 percent of men were aware of prostate cancer clinical trials at the time of diagnosis.

Researchers at the Coalition of Cancer Cooperative Groups and Northwestern University, who conducted the study, say that it's critical for men to know their options after being diagnosed with prostate cancer.

| Go to story